NASDAQ: IRTC

iRhythm Holdings, Inc.

CIK 0001388658 · Surgical & Medical Instruments

Mid Revenue $747M Assets $1.0B as of Jul 12, 2026

Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.

Sign up free

Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.

8-K Filed Jun 15, 2026 · Period ending Jun 10, 2026

iRhythm discloses material cybersecurity breach exposing patient health data and proprietary info

4 material changes detected. Sign up free to read the summary.

8-K Filed Jun 5, 2026 · Period ending Jun 3, 2026 Red flag

iRhythm settles securities class action for $45M, mostly covered by insurance

5 material changes detected. Sign up free to read the summary.

Partner

Trade IRTC commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed May 28, 2026 · Period ending May 27, 2026

iRhythm shareholders approve new 2026 equity plan, elect directors at annual meeting

5 material changes detected. Sign up free to read the summary.

10-Q Filed Apr 30, 2026 · Period ending Mar 31, 2026

iRhythm Q1 revenue jumps 26% to $199M; profitability turns positive amid new DOJ probe

5 material changes detected. Sign up free to read the summary.

8-K Filed Apr 30, 2026 · Period ending Apr 30, 2026

iRhythm reports Q1 2026 financial results in routine earnings disclosure

1 material change detected. Sign up free to read the summary.

8-K Filed Apr 1, 2026 · Period ending Mar 30, 2026 Red flag

iRhythm switches auditors from PwC to KPMG, cites no accounting disputes

4 material changes detected. Sign up free to read the summary.

8-K Filed Mar 12, 2026 · Period ending Mar 12, 2026

iRhythm appoints Jason Patten to Board and Audit Committee effective March 12

3 material changes detected. Sign up free to read the summary.

10-K Filed Feb 19, 2026 · Period ending Dec 31, 2025

iRhythm swings to positive Adjusted EBITDA amid 26% revenue growth, $10M IP litigation costs

5 material changes detected. Sign up free to read the summary.

10-Q Filed Oct 30, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed May 1, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

10-K Filed Feb 20, 2025 · Period ending Dec 31, 2024

Summary not yet generated.